Working with a large practice in the Plano/Frisco area north of Dallas, McCullough and his team administered this protocol to some eight hundred patients and demonstrated an 85 percent reduction in hospitalization and death. Another practice led by the legendary Dr. Vladimir Zelenko in Monroe, New York showed similar astonishing results.61
Independent physicians unaffiliated with the government or the universities that are so dependent on Dr. Fauci’s good favor were discovering new COVID treatments by the day. Researchers treated 738 randomly selected Brazilian COVID-19 patients with another adjuvant, fluvoxamine, identified early in the pandemic for its potential to reduce cytokine storms.62 Another 733 received a placebo between Jan. 20 and Aug. 6 of 2021. The researchers tracked every patient receiving fluvoxamine during the trial for 28 days and found about a 30-percent reduction in events among those receiving fluvoxamine compared to those who did not. Like almost all the other remedies, it is cheap and proven safe by long use. Fluvoxamine costs about $4 per 10-day course. Fluvoxamine has been used since the 1990s, and its safety profile is well known.63
“Hydroxychloroquine and ivermectin are not necessary nor sufficient on their own—there are plenty of molecules that treat COVID,” says McCullough. “Even if hydroxychloroquine and ivermectin had become so politicized that no one wanted to allow these drugs to be used, we could use other drugs, anti-inflammatories, antihistamines, as well as anticoagulants and actually stop the illness and again, treat it to reduce hospitalization and death.”
When the pandemic started, most of the other medical practices in the Detroit area shut down, Dr. David Brownstein told me. “I had a meeting with my staff and my six partners. I told them, ‘We are going to stay open and treat COVID.’ They wanted to know how. I said, ‘We’ve been treating viral diseases here for twenty-five years. COVID can’t be any different.’ In all that time, our office had never lost a single patient to flu or flu-like illness. We treated people in their cars with oral vitamins A, C, and D, and iodine. We administered IV solution outside all winter with IV hydrogen peroxide and vitamin C. We’d have them put their butts out the car window and shot them up with intramuscular ozone. We nebulized them with hydrogen peroxide and Lugol’s iodine. We only rarely used ivermectin and hydroxychloroquine. We treated 715 patients and had ten hospitalizations and no deaths. Early treatment was the key. We weren’t allowed to talk about it. The whole medical establishment was trying to shut down early treatment and silence all the doctors who talked about successes. A whole generation of doctors just stopped practicing medicine. When we talked about it, the whole cartel came for us. I’ve been in litigation with the Medical Board for a year. When we posted videos from some of our recovered patients, they went viral. One of the videos had a million views. FTC filed a motion against us, and we had to take everything down.” In July 2020, Brownstein and his seven colleagues published a peer-reviewed article describing their stellar success with early treatment. FTC sent him a letter warning him to take it down. “No one wanted Americans to know that you didn’t have to die from COVID. It’s 100 percent treatable,” says Dr. Brownstein. “We proved it. No one had to die.”
“Meanwhile,” adds Dr. Brownstein, “we’ve seen lots of really bad vaccine side effects in our patients. We’ve had seven strokes—some ending in severe paralysis. We had three cases of pulmonary embolism, two blood clots, two cases of Graves’ disease, and one death.”
Repurposed medicines, the record shows, could also have drastically reduced death among hospitalized patients. One of Dr. Kory’s cofounders of FLCCC, Houston Memorial Medical Center’s Chief Medical Officer, Dr. Joe Varon, worked 400 days in a row, seeing between 20–30 patients/day. Using ivermectin and a cocktail of anti-inflammatories, steroids, and anticoagulants since Spring 2020, Dr. Varon lowered hospital mortality among ICU COVID patients to about 4.1 percent, compared to well over 23 percent nationally. “Even in the ICUs where patients were coming in undertreated, we were able to dramatically reduce mortality,” says Dr. Kory.
“Almost anything you do in the nursing homes—basically, any combination of the various components of these protocols—reduces mortalities by at least 60 percent,” McCullough told me. A 2021 paper in Medical Hypotheses supports McCullough’s claim.64 That study by twelve physician coauthors shows that diverse combinations of many of these and similar medications dramatically lower death rates in a variety of nursing homes. The study concludes that even the most modest early medical therapy combinations were associated with 60 percent reductions in mortality. Says Dr. McCullough, “Therapeutic nihilism was the real killer of America’s seniors.”
McCullough’s findings may be conservative. Early in the pandemic, two Spanish nursing homes simultaneously experimented with early treatment with cheap, available repurposed drugs and achieved 100 percent survival among infected residents and staff. Between March and April 2020, COVID-19 struck two elder care facilities in Yepes, Toledo, Spain. The mean age of residents in those locations was 85, and 48 percent were over 80 years old. Within three months, 100 percent of the residents at both locations had caught the virus. By the end of June, 100 percent of residents and half the workers were seropositive for COVID, meaning they had endured infection and recovered. None of them went to the hospital and none died. None had adverse drug effects. Local doctors rapidly discovered early treatment with the same sort of remedies that McCullough was championing: antihistamines, steroids, antibiotics, anti-inflammatories, aspirin, nasal washes, bronchodilators, and blood thinners. In pooled data, 28 percent of the residents in similar nursing homes in the same region over the same time period died. That study supports the experience of front-line physicians that cheap available, repurposed drugs can easily prevent hospitalizations and deaths.65